Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase IIb Efficacy and Safety Study of Adjunctive AZD6765 in Patients With Major Depressive Disorder (MDD) and a History of Inadequate Response to Antidepressants
Conditions
Interventions
AZD6765 iv
AZD6765 iv
+1 more
Locations
44
United States
Research Site
Chino, California, United States
Research Site
Lond Beach, California, United States
Research Site
San Diego, California, United States
Research Site
Stanford, California, United States
Research Site
New Heaven, Connecticut, United States
Research Site
Fort Lauderdale, Florida, United States
Start Date
December 16, 2011
Primary Completion Date
August 26, 2013
Completion Date
August 26, 2013
Last Updated
April 11, 2017
NCT07523048
NCT07226661
NCT07115329
NCT06793397
NCT07025720
NCT06132581
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions